Načítá se...
EUROPA: Has Anything New Been Learned With Angiotensin‐Converting Enzyme Inhibitors?
The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) involved 12,218 patients with stable coronary artery disease. Patients in this trial were randomized to the angiotensin‐converting enzyme inhibitor perindopril (8 mg/d) or placebo in additio...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Le Jacq Communications, Inc.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109638/ https://ncbi.nlm.nih.gov/pubmed/14872148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2004.02846.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|